TSS:Rfhg 208630.1

Basic information about the TSS

---

TSS ID: rfhg_208630.1 Species: human Chr: chr19		Start: 14517423 End: 14517440 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3044536,EH38E1941414)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000676577.1:-129 GeneID: 3337 HGNC/MGI_ID: HGNC:5270 UniProt_ID: Nearer transcript ids and distances: ENST00000677204.1:-260 ENST00000598235.2:-395 NM_001300914.2:-497 view more...

Gene_name: DNAJB1 Gene_symbol: DNAJB1 Gene_synonyms: Hsp40 RSPH16B Sis1 Gene_source: HGNC:5270

TATA-Box annotation

---

Distance to TSS:	431
Nearest PromoterID:	NM_001300914
Entrez ID:	3337
Nearest Unigene:	Hs.515210
Nearest Refseq:	NM_006145
Nearest Ensembl:	ENSG00000132002
Gene Name:	DNAJB1
Gene Alias:	HSPF1|Hdj1|Hsp40|RSPH16B|Sis1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DNAJB1 p2@DNAJB1 p3@DNAJB1 p4@DNAJB1 p5@DNAJB1
Sample		p1@DNAJB1	p2@DNAJB1	p3@DNAJB1	p4@DNAJB1	p5@DNAJB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	35.84	20.45	1.36	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.58	19.62	2.02	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	35.11	19.87	1.16	0.58	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.91	14.97	0.42	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.02	14.17	0.00	0.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.23	16.47	0.78	0.97	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	24.19	21.57	0.65	1.09	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	18.89	18.65	0.97	0.73	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	19.88	17.74	1.28	0.85	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.13	17.39	0.00	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	19.81	12.94	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.48	17.89	0.81	2.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.57	8.38	0.81	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.04	5.56	0.60	1.35	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.78	7.46	0.44	1.76	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.85	7.29	0.50	1.01	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.23	5.68	0.66	1.09	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.70	7.59	0.42	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.80	8.53	1.07	1.60	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.33	9.03	0.45	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.01	8.02	0.53	0.53	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.22	8.11	0.35	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.60	7.37	0.65	0.78	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.18	9.71	1.21	0.97	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	28.89	10.06	0.00	1.55	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.69	6.65	0.63	1.58	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.23	7.14	0.55	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	40.08	7.54	0.47	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.14	7.91	0.32	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	33.48	6.88	0.72	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	24.49	6.49	0.63	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.73	6.06	0.59	1.37	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.96	4.85	0.63	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.57	7.42	0.33	0.16	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.36	3.55	0.19	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.25	5.56	0.00	0.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.91	7.15	0.61	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.96	6.25	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.67	3.24	0.81	0.54	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	15.84	6.48	0.48	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.94	6.12	0.71	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.91	7.47	0.15	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.34	7.80	0.63	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.51	5.94	0.17	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.05	6.02	0.20	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.54	4.42	0.47	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.80	6.00	0.72	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.94	3.87	0.60	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	5.98	0.96	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.67	5.46	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.61	5.12	1.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.78	5.11	0.67	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	4.61	6.39	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.63	3.65	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	11.75	0.84	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	7.35	0.46	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.43	11.34	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.42	6.10	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	6.92	7.86	0.31	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	4.23	0.71	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	4.49	3.93	0.00	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	7.17	0.00	1.59	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.08	6.80	1.02	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.15	6.82	0.65	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.16	9.58	0.35	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	0.00	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.53	6.34	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.39	7.44	0.00	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	13.14	12.20	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.94	8.94	0.00	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.97	6.81	0.93	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.84	3.97	0.61	1.53	0.31
Adipocyte - breast, donor1	11376-118A8	7.29	8.39	1.11	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	13.32	7.86	0.80	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	9.54	10.18	1.02	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	14.20	11.21	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	18.42	7.03	0.67	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	11.48	8.29	1.28	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	5.50	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	8.58	0.00	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	29.54	10.08	0.52	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	18.19	12.71	1.37	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	7.72	9.27	1.54	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	10.04	13.10	2.51	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	15.87	11.17	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	40.54	8.45	0.72	0.32	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	10.33	6.46	0.97	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	13.33	5.33	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	6.68	0.56	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	26.62	7.49	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	12.31	8.79	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.38	8.18	0.33	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	17.66	4.26	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	61.22	12.82	0.66	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	92.87	7.53	0.00	0.72	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	9.58	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	64.95	13.13	0.54	0.54	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	61.92	18.41	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	69.44	9.04	0.21	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	14.30	11.44	0.80	1.60	0.23
Anulus Pulposus Cell, donor2	11463-119B5	17.63	9.80	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.07	5.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.23	9.12	0.87	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.64	8.67	0.60	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	5.06	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	5.28	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.82	5.85	0.00	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.11	9.71	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	7.13	0.00	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.08	6.40	0.75	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.14	10.89	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.54	8.73	1.48	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	24.57	9.55	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.09	5.43	0.45	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	13.39	8.57	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.06	7.18	0.76	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.15	6.68	0.53	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	6.83	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.09	6.14	0.17	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	2.40	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.35	8.06	1.54	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.14	8.74	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.35	6.45	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	9.69	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.67	9.12	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	22.23	5.56	0.86	0.43	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.23	7.23	1.03	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.14	9.38	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	20.26	6.43	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.99	7.13	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	4.68	1.75	0.00	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.75	4.52	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	8.32	1.19	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	6.10	0.51	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	16.81	4.58	0.76	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	7.62	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	6.47	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.61	7.62	1.06	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.83	7.25	0.29	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	4.72	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.90	5.76	0.68	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	6.95	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	8.45	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.51	6.22	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	7.82	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	6.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.18	5.52	0.92	0.69	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.88	3.56	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.13	6.81	0.00	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.65	6.12	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.69	7.65	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.41	6.43	0.00	0.89	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	9.15	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.85	7.20	0.55	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.27	7.15	0.26	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.45	8.00	0.00	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	22.84	19.77	1.84	0.86	0.12
Astrocyte - cerebellum, donor2	11580-120F5	26.36	16.94	0.51	0.51	0.34
Astrocyte - cerebellum, donor3	11661-122F5	20.97	18.88	1.47	1.05	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	13.59	25.80	2.44	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	35.43	23.78	1.13	2.43	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	19.99	23.57	1.94	1.19	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	11.93	20.76	1.83	0.34	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	16.16	19.04	2.00	0.63	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11.61	19.80	1.93	0.91	0.11
Basophils, donor1	12241-129G9	63.29	43.68	1.57	0.00	0.78
Basophils, donor2	12242-129H1	87.31	61.34	1.08	0.72	0.36
Basophils, donor3	12243-129H2	46.60	32.63	0.88	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	75.25	7.76	0.22	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	48.92	6.86	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	33.89	5.65	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	46.58	4.78	0.62	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	30.17	6.68	0.00	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	51.46	7.02	0.36	1.08	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.00	13.29	1.24	1.34	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.67	14.21	1.16	2.10	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	20.15	25.58	2.24	1.92	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	34.38	21.98	1.13	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	38.79	20.97	2.04	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	50.27	30.08	0.66	0.22	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	18.11	15.57	1.13	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.88	19.33	1.52	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	19.40	15.45	1.97	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	20.96	18.21	1.01	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	34.10	12.67	0.30	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	85.76	15.63	0.71	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	52.73	16.57	0.33	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	71.76	16.56	1.10	0.28	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	179.25	21.57	0.25	0.50	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	67.16	12.73	0.98	0.20	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	76.03	11.75	0.00	0.18	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	174.32	15.23	0.22	0.00	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	135.33	11.24	0.23	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	257.68	16.90	1.06	0.00	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	298.42	16.64	1.11	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	26.92	13.09	0.45	0.00	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	31.53	13.57	0.60	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	103.27	14.37	0.62	0.00	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	44.84	8.47	0.00	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	54.29	8.37	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	153.63	6.11	0.44	0.00	4.80
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	29.59	16.95	0.54	0.00	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	45.36	13.78	0.70	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	130.03	19.78	0.42	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.21	8.45	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	44.74	9.86	0.00	0.00	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	107.49	10.97	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	106.54	13.95	0.17	0.35	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	66.16	10.78	0.00	0.00	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	141.18	19.83	0.65	0.43	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	25.80	9.83	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	34.54	8.11	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	89.78	6.26	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	11.55	25.72	0.44	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	9.47	27.95	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	11.70	27.51	0.87	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	9.03	33.48	2.02	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	6.11	29.51	1.57	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	8.25	34.56	2.90	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	14.03	33.68	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	9.22	31.62	1.76	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	11.16	30.95	1.68	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	34.55	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	19.66	27.12	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	36.25	3.11	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	39.98	44.24	4.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.40	32.16	2.14	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.25	21.76	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	15.69	32.16	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	23.73	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	36.99	30.41	2.47	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	16.68	20.31	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	19.18	23.73	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	21.82	50.91	7.68	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	18.78	47.54	7.19	0.80	1.20
CD34+ Progenitors, donor1	11545-120B6	11.04	19.08	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	56.74	30.34	1.12	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.92	20.29	3.01	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	15.11	26.61	0.23	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	368.48	120.33	4.64	1.07	0.71
CD4+ T Cells, donor2	11306-117C1	358.84	112.67	1.84	1.84	4.90
CD4+ T Cells, donor3	11382-118B5	484.63	75.64	1.52	0.61	5.18
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	16.08	30.63	1.53	0.77	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	22.91	24.93	2.70	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	26.45	27.60	0.57	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	469.82	151.24	3.79	0.95	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	379.96	132.74	2.11	3.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	309.85	98.89	0.00	9.89	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	21.97	24.13	0.43	1.73	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.72	23.05	1.02	0.51	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.02	20.80	0.97	1.13	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	270.32	67.24	1.34	1.34	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	202.65	68.48	1.75	1.05	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	219.55	71.72	0.44	3.08	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.46	24.88	1.26	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.78	16.21	1.45	2.29	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	17.37	19.38	1.34	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	344.00	113.67	2.72	5.44	2.45
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	284.05	137.20	2.14	4.29	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	322.78	121.94	1.79	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	22.44	30.41	1.11	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.45	25.56	0.65	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.69	26.90	1.26	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	407.01	98.09	4.04	3.03	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	302.41	81.45	0.87	1.30	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	300.28	69.73	1.74	0.87	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	105.90	76.21	4.45	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	89.55	49.85	1.85	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	76.77	61.42	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	97.48	75.60	3.88	1.11	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	86.38	66.50	1.72	0.98	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	78.54	41.58	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	81.29	66.25	2.15	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	81.71	4.15	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	285.82	92.00	0.65	0.65	0.98
CD8+ T Cells, donor2	11307-117C2	241.03	79.59	0.75	0.38	3.00
CD8+ T Cells, donor3	11383-118B6	419.38	94.68	1.01	1.51	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.30	8.26	0.23	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.67	6.71	0.96	1.20	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.04	6.02	0.27	1.92	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.60	7.51	0.90	1.20	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.48	7.44	0.96	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.00	6.37	0.91	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.34	8.04	0.00	1.30	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.11	10.26	0.79	1.32	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.02	8.91	0.23	0.70	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.96	6.64	0.00	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.84	4.94	0.29	1.74	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.33	8.26	0.80	2.13	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	104.18	2.19	0.44	1.75	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	105.20	5.01	0.00	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	78.32	3.73	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.21	5.04	0.00	1.80	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.07	8.06	1.15	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.02	6.84	0.71	0.94	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.92	10.14	0.32	1.27	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.84	9.84	0.62	1.23	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.31	9.94	0.00	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.00	6.50	0.76	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.43	6.70	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	7.56	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	137.31	12.85	0.80	4.82	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	141.98	12.59	0.00	3.50	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	147.26	12.02	0.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	40.21	12.79	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	12.35	6.92	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	26.20	10.31	0.53	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	11.44	8.67	0.35	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	12.79	12.79	0.36	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.77	9.33	0.57	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	24.17	12.53	0.90	4.48	0.00
Chondrocyte - re diff, donor3	11411-118E7	29.93	23.46	1.62	1.62	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	12.51	16.18	0.80	2.75	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	10.90	9.83	0.43	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	13.89	10.09	0.80	0.88	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	68.04	57.77	8.62	17.33	0.55
Corneal Epithelial Cells, donor1	11526-119I5	56.21	8.78	0.00	0.88	0.00
Corneal Epithelial Cells, donor2	11606-120I4	68.26	3.41	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	66.98	6.65	0.77	0.26	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.57	9.91	0.99	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.88	8.83	1.58	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	13.80	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.82	10.04	0.22	0.11	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	5.81	17.42	1.71	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.10	18.93	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	8.23	19.36	2.42	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	19.85	10.17	0.17	0.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	17.60	8.21	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.03	5.37	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	18.48	5.50	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	17.74	4.94	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	13.41	7.53	0.47	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	19.63	9.47	0.70	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.74	4.88	0.00	0.66	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.91	4.56	0.00	1.52	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	11.84	3.95	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	16.64	6.83	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	16.14	5.21	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.93	4.68	0.28	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	17.61	6.80	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	13.10	8.39	1.05	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	10.31	6.59	0.50	0.87	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.86	4.78	0.00	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	15.02	6.11	0.12	1.10	0.12
Endothelial Cells - Vein, donor1	11267-116G7	14.79	6.83	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	24.45	6.99	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	14.76	6.12	0.00	0.00	0.31
Eosinophils, donor1	12244-129H3	335.43	137.22	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	118.82	202.98	11.55	1.65	3.30
Eosinophils, donor3	12246-129H5	267.51	164.07	3.57	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	41.54	4.89	0.49	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	81.13	6.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.01	10.67	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.88	4.93	0.00	0.33	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.47	9.10	0.33	1.08	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.01	10.55	0.49	0.24	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.38	5.87	1.09	0.41	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.66	7.91	0.42	0.53	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	13.44	7.64	0.00	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.93	10.63	0.66	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	21.77	9.98	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	7.58	13.64	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.20	9.94	1.42	0.63	0.00
Fibroblast - Cardiac, donor4	11452-119A3	14.25	9.70	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.18	7.99	0.13	0.25	0.25
Fibroblast - Cardiac, donor6	11460-119B2	23.19	8.03	0.45	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.78	15.14	2.14	0.80	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	7.33	12.08	2.16	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	13.18	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	8.53	13.84	0.23	1.15	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	23.07	11.19	1.02	1.70	0.00
Fibroblast - Dermal, donor1	11269-116G9	10.57	7.75	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.98	15.09	1.89	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.12	10.52	0.48	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	11.87	9.83	0.57	0.34	0.34
Fibroblast - Dermal, donor5	11454-119A5	15.00	11.17	0.17	1.22	0.70
Fibroblast - Dermal, donor6	11458-119A9	23.88	19.33	0.97	0.81	0.16
Fibroblast - Gingival, donor1	11237-116D4	14.16	6.46	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.65	15.46	1.57	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	22.14	14.89	0.66	1.45	1.19
Fibroblast - Gingival, donor3	11394-118C8	21.37	8.03	0.48	0.58	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	11.43	13.51	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.52	8.63	1.23	0.35	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.00	15.43	1.40	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.28	11.63	0.95	0.81	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.06	11.29	1.41	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.51	9.07	0.88	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	7.77	14.04	2.18	0.68	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.67	12.51	1.10	0.33	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	5.14	10.86	0.59	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	19.03	16.31	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	13.43	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	24.27	13.08	0.21	1.48	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	50.81	16.66	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	12.59	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	13.43	5.32	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	38.97	16.64	0.41	3.65	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	11.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.49	14.94	1.36	1.75	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.81	16.84	0.61	1.67	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	30.29	5.81	0.00	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.26	12.98	0.38	0.38	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.99	12.15	1.35	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	7.77	12.18	0.93	0.23	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.37	9.17	0.55	0.44	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	43.89	14.02	0.61	1.42	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	22.05	2.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.44	9.49	1.58	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.11	5.36	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.77	12.08	0.71	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.49	12.02	1.18	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.82	8.72	1.81	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.52	11.77	0.22	0.22	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.47	8.86	1.01	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	13.95	13.13	1.64	0.49	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.24	12.83	0.80	0.60	0.00
Fibroblast - skin normal, donor2	11561-120D4	16.68	17.58	1.31	0.60	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	19.95	11.79	0.91	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.36	13.92	1.33	1.24	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	32.82	14.70	0.51	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	11.50	8.87	0.33	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	27.27	14.81	1.28	0.75	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	13.49	12.99	0.67	0.34	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.29	11.13	1.10	1.10	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	73.21	10.46	0.00	0.87	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	59.81	6.76	0.00	0.35	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	55.17	8.07	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	69.75	6.90	0.00	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.83	25.26	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	2.55	16.59	1.28	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	9.70	25.96	2.57	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	13.79	38.61	5.24	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.06	23.06	2.97	0.68	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	12.28	25.56	2.77	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.01	37.27	3.70	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	31.64	18.92	3.91	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	10.61	20.78	1.33	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.81	25.72	1.41	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.63	24.75	1.23	0.99	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.19	18.80	2.42	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	26.14	18.96	0.99	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	25.75	19.24	0.42	0.42	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.48	10.78	0.41	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.19	18.71	0.46	1.14	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.88	16.69	0.37	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.73	15.52	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	16.55	25.71	0.59	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	23.84	22.89	1.43	0.64	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	22.12	17.87	1.34	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.72	20.57	1.01	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	20.87	24.43	1.19	1.19	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.71	15.78	1.86	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.77	25.81	1.77	0.62	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.54	19.98	1.37	1.54	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.36	26.45	1.00	1.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.39	18.14	1.66	0.67	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.29	19.19	2.25	1.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.30	19.19	1.24	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.68	25.48	1.15	1.50	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.18	14.01	1.50	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	17.41	20.28	2.87	1.54	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.13	29.03	1.72	1.35	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.32	14.91	1.46	1.30	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	16.68	23.09	1.60	0.32	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.72	21.22	0.57	1.42	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	16.29	13.60	0.63	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.12	14.29	0.91	2.43	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.55	19.97	0.84	1.15	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.13	15.15	1.10	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.32	19.36	1.12	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.11	13.70	0.37	0.83	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.72	11.77	0.27	1.34	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.14	9.95	0.31	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.25	13.73	0.65	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.89	11.66	0.27	1.63	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.44	9.59	1.47	0.92	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.16	10.75	0.88	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	9.92	16.86	0.99	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.68	12.00	0.66	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.15	13.11	0.61	1.21	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.35	19.06	1.78	2.03	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	15.53	27.67	1.99	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	22.96	29.89	1.23	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	14.93	31.71	3.27	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.07	23.47	3.13	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.80	20.91	2.83	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.07	28.59	2.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	34.65	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	14.70	25.92	1.55	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	17.65	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	31.30	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.02	25.06	3.25	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.12	21.83	2.06	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.82	24.05	3.08	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	10.13	19.28	2.94	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.03	25.17	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.40	27.04	3.50	0.64	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	13.93	29.89	1.36	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	16.71	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.04	35.51	2.29	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.43	25.16	2.66	1.18	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1.69	8.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	13.67	24.02	2.90	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	9.90	22.55	2.07	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	26.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.38	15.38	2.31	1.15	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.45	18.58	1.96	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.03	18.06	2.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	8.48	31.98	1.93	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.02	32.52	2.05	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	32.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	6.61	24.54	4.72	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	10.26	20.52	4.22	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	8.14	24.93	4.07	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	8.38	21.14	2.39	0.40	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.31	27.63	2.47	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	33.05	2.36	2.36	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	6.42	29.17	6.42	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.02	32.04	2.63	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	14.41	33.91	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.74	16.71	1.19	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.13	23.78	2.91	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	12.55	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.16	8.73	1.66	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	7.87	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	14.91	6.34	0.32	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	16.71	4.60	0.00	0.42	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	38.87	11.37	0.93	0.23	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	43.04	13.84	0.51	0.34	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	45.05	10.92	1.59	0.23	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	40.44	12.79	0.77	0.22	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	39.97	14.18	1.07	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	45.86	13.13	0.65	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	36.12	9.96	0.62	0.50	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.36	9.61	0.17	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	39.41	9.61	0.64	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.59	6.72	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	14.71	14.71	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	23.63	16.23	0.71	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	18.89	12.35	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.81	9.09	0.17	0.17	0.70
Hepatocyte, donor1	11523-119I2	29.05	4.84	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	45.25	7.54	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	74.85	4.91	0.00	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	46.34	20.89	1.96	5.22	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	30.59	14.16	1.22	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.68	9.88	0.55	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	19.10	0.00	9.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	26.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	13.84	1.38	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	35.04	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	15.38	0.00	10.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	27.42	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	24.36	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	13.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	18.15	0.00	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	42.35	31.76	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	41.02	24.39	0.00	3.33	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	26.19	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	21.42	23.30	0.63	2.52	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	44.85	21.65	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.90	8.40	1.29	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	35.42	28.98	0.00	6.44	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	29.34	0.81	4.07	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.73	20.57	1.68	2.10	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	21.70	18.48	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	28.62	12.93	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.83	12.75	1.42	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	27.21	15.42	1.81	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	21.52	17.22	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	17.79	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.67	14.67	0.64	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	12.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	21.42	22.14	1.43	3.57	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	19.91	3.32	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.94	15.12	0.62	2.16	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	10.54	0.00	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	15.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	27.82	13.91	0.70	4.17	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	24.34	28.77	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	32.42	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	20.93	0.87	4.36	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	18.00	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	31.36	3.48	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	21.34	2.13	4.27	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	30.48	2.77	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	14.25	2.85	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	18.41	25.77	0.92	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	27.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	31.04	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	12.69	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	37.94	3.84	0.24	0.24	0.33
Keratinocyte - epidermal, donor2	11349-117G8	21.67	6.44	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	50.64	7.76	0.28	0.57	0.38
Keratinocyte - oral, donor1	11251-116E9	32.69	11.01	0.68	1.14	0.11
Keratocytes, donor1	11527-119I6	14.44	35.41	3.44	1.38	0.00
Keratocytes, donor2	11607-120I5	18.75	11.72	1.17	4.69	0.00
Keratocytes, donor3	11688-122I5	10.28	18.38	0.59	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	72.53	6.59	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	22.65	8.63	0.00	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	45.09	16.38	1.38	1.61	0.00
Lens Epithelial Cells, donor3	11690-122I7	18.57	9.28	1.11	0.50	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	15.65	5.22	0.12	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.21	3.35	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	9.92	3.94	0.00	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	5.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.98	3.47	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.10	3.77	0.11	0.65	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.18	3.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.19	5.31	0.51	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.68	3.80	0.14	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	12.66	5.14	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.67	3.30	0.00	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.15	3.33	0.00	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.16	2.44	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.07	4.77	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.64	4.12	0.14	0.27	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	13.24	3.08	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.96	3.74	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.06	5.86	0.18	0.73	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.20	5.27	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.18	3.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.94	3.24	0.00	0.25	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	2.91	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	10.77	4.85	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.84	2.88	0.00	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.41	1.04	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.05	2.93	0.21	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.02	3.31	0.00	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	4.13	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	11.85	3.39	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	11.77	3.82	0.21	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	3.39	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.92	3.64	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.27	4.21	0.12	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.03	4.81	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.40	3.46	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.70	3.16	0.00	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.54	3.54	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.74	2.43	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.22	3.78	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.64	3.20	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.09	2.91	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.11	5.91	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	6.80	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.09	4.90	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.36	3.53	0.00	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.29	7.43	0.25	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.04	5.12	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	12.53	5.67	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	72.51	13.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	65.97	13.81	1.53	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	71.25	8.91	0.00	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	52.89	11.00	0.00	3.39	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	78.77	9.85	0.00	2.81	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	61.64	16.81	2.80	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.98	8.24	2.58	1.55	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	85.64	8.33	2.38	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	65.37	11.54	1.58	1.58	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	45.95	7.56	0.87	1.45	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	88.23	8.55	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	76.96	16.80	1.08	1.49	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	48.27	11.81	0.00	3.59	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	80.45	10.23	0.35	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	59.30	12.66	0.00	4.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.47	12.73	0.51	2.55	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	84.31	12.81	1.07	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	76.90	13.04	0.57	1.70	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	63.20	18.41	0.00	1.84	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	127.21	15.49	0.82	4.08	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	82.05	10.62	0.21	1.25	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	49.89	5.61	0.84	1.96	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	144.25	12.36	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	77.80	8.13	0.29	1.45	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	42.75	5.38	0.30	0.60	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	76.35	7.75	0.00	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	100.74	12.02	0.35	2.12	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	50.52	7.38	0.74	1.84	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	84.04	14.97	2.30	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	80.20	13.05	1.54	1.92	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.29	13.02	1.70	2.26	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	76.30	12.31	3.28	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	87.67	10.39	0.45	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	41.65	12.21	0.72	5.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	85.15	9.71	1.49	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	80.64	9.66	0.00	1.49	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.09	8.18	0.43	1.72	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	97.62	7.71	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	83.96	12.33	0.67	2.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	74.81	7.84	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	127.27	5.69	0.71	4.27	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	97.96	12.37	1.03	3.78	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	70.85	8.05	1.07	2.68	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	119.86	12.79	0.67	2.69	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	91.86	9.63	0.37	2.22	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	72.10	12.79	1.16	4.65	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	120.58	9.52	1.06	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	94.44	13.61	0.40	1.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	59.60	8.72	0.73	2.91	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	108.08	21.46	0.00	1.53	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	103.10	10.85	0.99	3.45	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	57.40	7.53	1.88	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	128.22	17.10	0.50	2.01	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	94.18	18.48	0.45	2.70	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	6.88	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	144.29	16.92	0.45	4.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	114.18	16.03	1.56	3.13	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	71.25	11.22	1.32	2.64	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	125.58	18.16	1.04	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	107.20	17.07	1.31	4.81	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	63.18	11.18	0.00	1.12	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	135.58	18.11	1.32	2.65	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	108.00	23.53	0.77	3.47	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	72.41	10.63	0.00	3.04	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	120.64	16.34	1.92	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	105.35	13.52	0.80	1.59	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	91.75	12.15	1.82	1.82	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	112.75	10.38	0.69	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	142.50	16.72	1.14	1.14	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	88.82	17.56	2.07	3.61	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	121.54	9.67	0.60	1.81	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	133.73	14.89	0.32	2.22	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	97.56	14.93	0.53	2.13	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	148.27	10.92	0.00	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	137.81	21.08	1.54	1.54	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	65.78	12.03	0.71	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	129.95	17.02	0.00	0.57	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	106.92	13.31	0.42	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	46.98	10.96	0.00	3.13	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	93.11	13.78	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	101.29	16.26	0.93	2.32	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	61.55	11.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	111.74	14.97	0.00	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	113.55	14.95	1.21	2.02	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	61.49	14.68	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	102.25	11.56	0.89	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	105.43	21.09	0.57	1.71	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	82.83	13.04	0.00	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	77.70	13.13	0.55	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	137.64	20.49	2.67	3.56	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	91.24	19.24	1.56	2.34	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	104.77	9.95	0.66	1.33	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	91.46	14.55	4.16	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	13.90	11.85	1.60	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	9.36	9.36	1.47	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	17.17	13.24	0.92	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	52.04	7.43	1.06	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	38.19	7.29	0.16	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	44.75	5.56	0.42	0.56	0.69
Mammary Epithelial Cell, donor1	11273-116H4	29.59	15.15	1.10	0.80	0.10
Mammary Epithelial Cell, donor2	11350-117G9	26.64	10.13	0.29	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	35.92	6.24	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	30.51	18.30	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	27.90	17.74	0.87	1.73	0.11
Mast cell, donor2	11565-120D8	827.93	48.14	2.38	0.89	1.49
Mast cell, donor3	11566-120D9	270.82	44.80	3.60	1.35	1.13
Mast cell, donor4	11567-120E1	1570.96	41.13	3.19	0.35	4.25
Mast cell, expanded and stimulated, donor5	11940-126A5	11.87	18.52	1.00	2.33	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	7.59	12.26	0.00	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	16.29	22.60	1.26	1.61	0.11
Mast cell, expanded, donor8	11941-126A6	21.93	17.07	1.51	1.34	0.17
Melanocyte - dark, donor1	11502-119F8	15.42	4.48	0.10	0.80	0.00
Melanocyte - dark, donor2	11582-120F7	14.88	7.61	0.00	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	37.52	11.81	0.58	1.16	0.07
Melanocyte - light, donor1	11274-116H5	20.22	9.40	1.18	0.00	0.47
Melanocyte - light, donor2	11351-117H1	18.43	10.92	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	18.21	11.27	0.87	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	34.05	12.91	0.62	0.21	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	24.47	8.07	0.27	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	15.54	15.00	0.54	1.07	0.00
Meningeal Cells, donor1	11493-119E8	30.52	22.21	1.36	1.24	0.12
Meningeal Cells, donor2	11573-120E7	36.09	17.17	0.00	1.32	0.00
Meningeal Cells, donor3	11654-122E7	13.61	15.81	0.98	0.57	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	19.11	7.70	0.29	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.87	6.44	0.50	0.60	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	6.57	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	5.23	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	8.61	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.01	7.20	0.85	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.09	8.04	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	22.20	14.28	0.66	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.76	12.42	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	25.37	12.28	0.00	0.61	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.52	6.93	0.28	1.66	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.52	12.64	1.12	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.66	10.53	0.26	0.92	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.35	13.35	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	15.37	8.97	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.05	17.37	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.71	7.82	0.31	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	22.50	16.69	1.45	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	25.19	12.20	0.27	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	28.03	11.01	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	22.19	8.74	0.36	0.65	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	12.15	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	13.05	11.82	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.42	7.95	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	13.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.71	9.92	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.92	5.39	0.62	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.27	11.76	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	12.10	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	20.73	10.97	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.46	7.13	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	7.96	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	6.08	1.14	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	3.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.28	3.61	0.64	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	3.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	15.80	4.17	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.05	6.27	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.27	5.23	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.75	4.37	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.20	5.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.95	6.32	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.72	7.51	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.56	5.33	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.60	4.38	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	2.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	7.61	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.59	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	4.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	3.84	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	3.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	7.51	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	3.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	4.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.23	10.41	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	4.87	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	4.44	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.13	3.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.62	6.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	7.86	10.10	0.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.99	4.57	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	3.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.33	9.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.18	6.68	0.42	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	10.16	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	9.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.49	7.60	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.74	8.81	0.26	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.15	6.01	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.54	9.61	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.87	9.88	1.20	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.37	6.64	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.82	6.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.72	9.51	0.66	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.20	3.03	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	4.83	6.25	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.80	10.08	1.72	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	6.52	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.59	6.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.53	13.84	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	4.12	7.01	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	4.76	9.83	1.19	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	7.53	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	7.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.89	11.50	0.99	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	4.21	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.14	13.64	0.79	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	13.97	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.90	9.01	1.50	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.19	13.05	0.80	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.60	13.12	0.45	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	8.10	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	3.66	13.19	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	12.44	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	11.22	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	23.18	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	7.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.85	3.79	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1451.83	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	324.26	2.54	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	472.94	4.86	0.00	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	459.17	3.02	0.00	0.00	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5122.02	5.71	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	7506.90	9.79	0.00	0.00	22.84
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	769.90	19.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	3400.80	12.55	12.55	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.50	9.48	0.22	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.97	8.36	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	3.34	0.67	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.10	2.92	0.00	0.83	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.55	13.69	1.14	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	14.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	3.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	3.68	0.00	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.79	2.09	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.97	4.65	0.93	0.70	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	5.94	2.43	0.27	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.98	9.25	0.21	1.05	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3.47	3.97	0.00	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	3.52	5.41	0.54	1.08	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.80	4.31	0.00	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.14	6.21	0.33	0.82	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.75	9.84	0.73	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.24	1.06	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	4.20	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.59	5.58	0.66	1.97	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.25	4.55	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	10.23	6.35	0.18	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	5.63	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.06	6.90	1.84	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.43	8.03	0.96	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.62	10.35	0.34	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	17.70	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.92	8.69	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.77	5.08	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.88	9.49	0.47	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.30	4.72	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.33	6.00	0.33	0.67	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.96	5.41	0.90	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.13	2.78	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	8.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	11.73	8.32	0.76	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.12	3.58	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	6.54	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.76	7.69	0.90	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	5.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.98	5.98	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.42	3.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.19	2.68	0.00	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.19	12.70	1.51	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	7.29	7.51	1.11	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	2.71	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	20.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.05	2.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.39	2.83	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.57	4.24	0.30	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	2.37	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	6.80	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	15.53	7.08	0.25	0.12	0.00
Myoblast, donor2	11322-117D8	10.36	10.74	0.19	0.19	0.19
Myoblast, donor3	11398-118D3	12.44	9.92	0.67	1.18	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	53.12	14.16	0.73	2.33	0.44
Natural Killer Cells, donor1	11230-116C6	117.16	70.11	0.92	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	156.21	66.04	1.81	1.81	3.32
Natural Killer Cells, donor3	11387-118C1	163.62	68.10	1.10	0.18	0.92
Neural stem cells, donor1	11275-116H6	17.06	27.22	1.81	4.72	0.00
Neural stem cells, donor2	11352-117H2	25.03	30.81	1.93	1.93	0.00
Neurons, donor1	11494-119E9	22.76	44.38	4.55	0.00	0.00
Neurons, donor2	11574-120E8	14.75	23.34	5.28	1.10	0.22
Neurons, donor3	11655-122E8	16.44	31.24	1.64	0.00	0.82
Neutrophils, donor1	11233-116C9	63.10	117.86	3.71	1.86	0.00
Neutrophils, donor2	11314-117C9	31.89	81.17	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	93.46	146.60	10.38	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	20.07	14.60	1.90	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	10.42	5.21	0.65	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	13.24	8.22	1.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.16	6.06	0.55	0.14	0.55
Olfactory epithelial cells, donor2	11934-125I8	10.42	6.95	0.29	0.14	0.43
Olfactory epithelial cells, donor3	11935-125I9	12.60	6.58	0.11	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	15.10	10.42	0.29	0.58	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	89.07	9.63	0.60	1.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	15.31	9.78	0.00	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	21.72	2.29	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	22.35	4.34	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	13.29	20.33	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	10.53	13.34	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	25.42	16.71	0.89	1.78	0.71
Pancreatic stromal cells, donor1	11249-116E7	11.62	13.90	0.84	1.85	0.08
Pericytes, donor1	11491-119E6	13.69	12.57	0.56	0.56	0.00
Pericytes, donor2	11571-120E5	19.47	19.47	1.58	0.91	0.00
Pericytes, donor3	11652-122E5	24.62	15.06	0.61	0.81	0.20
Perineurial Cells, donor1	11499-119F5	13.00	12.21	0.79	0.57	0.11
Perineurial Cells, donor2	11579-120F4	20.33	8.19	0.18	0.55	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	90.20	51.00	2.23	1.59	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	79.83	43.34	2.45	0.24	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	134.07	50.08	3.11	0.26	0.52
Placental Epithelial Cells, donor1	11278-116H9	67.21	27.98	2.15	0.96	0.24
Placental Epithelial Cells, donor2	11355-117H5	34.38	14.42	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	51.63	16.69	1.37	1.37	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.28	11.08	1.27	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	7.88	9.57	0.56	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.27	7.05	0.65	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	9.46	13.28	0.23	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	11.08	11.61	0.85	0.21	0.32
Preadipocyte - omental, donor2	11329-117E6	14.40	13.09	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	14.90	10.17	0.57	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	32.48	8.86	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	12.90	19.66	1.23	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	11.51	20.54	1.95	1.59	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	10.56	16.35	1.53	0.68	0.34
Preadipocyte - visceral, donor1	11280-116I2	8.29	13.88	1.02	1.30	0.00
Preadipocyte - visceral, donor2	11357-117H7	9.20	10.58	0.46	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	9.93	11.49	0.73	0.52	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.97	12.22	1.21	0.00	0.60
Prostate Epithelial Cells, donor2	11331-117E8	63.92	4.06	0.27	0.14	0.81
Prostate Epithelial Cells, donor3	11404-118D9	26.45	5.45	0.24	0.31	0.24
Prostate Stromal Cells, donor1	11254-116F3	18.45	10.48	0.91	0.46	0.23
Prostate Stromal Cells, donor2	11332-117E9	20.26	13.99	0.90	1.08	0.72
Prostate Stromal Cells, donor3	11405-118E1	17.10	9.70	0.52	0.63	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.91	10.22	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	23.91	9.84	0.62	0.83	0.35
Renal Epithelial Cells, donor1	11517-119H5	35.00	11.67	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	24.90	10.67	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	18.63	13.13	0.53	0.64	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	29.28	8.17	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.09	6.74	0.54	0.54	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.65	11.10	0.00	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	3.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	23.33	13.65	0.66	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	15.67	12.54	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	11.37	9.99	0.55	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	40.80	15.30	1.34	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.61	8.43	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	27.38	15.62	0.19	0.77	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.41	12.19	0.78	1.56	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	21.03	13.64	1.14	1.14	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	48.37	11.32	0.00	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.53	7.28	0.75	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	790.32	14.30	0.80	0.80	4.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	0.89	13.40	2.68	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	2.75	6.60	1.10	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	3.48	7.54	1.16	5.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.31	15.34	1.04	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	9.14	18.57	1.79	0.79	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	10.82	17.07	1.00	1.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	16.25	17.49	1.98	1.98	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	6.64	16.43	1.75	0.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	11.09	21.50	1.85	1.85	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.95	10.95	0.96	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	7.11	17.55	1.51	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	8.78	12.90	1.97	0.72	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	9.61	12.48	1.15	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.16	17.28	2.15	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	11.28	16.15	1.11	1.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	6.12	11.66	0.76	1.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	8.29	14.63	1.12	1.12	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	6.39	15.03	1.50	1.32	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.93	12.08	1.33	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	7.69	18.40	2.04	1.27	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	5.92	18.71	0.76	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.60	16.13	1.07	0.96	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	3.36	12.61	1.40	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	6.49	12.99	1.03	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.12	18.42	0.73	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	4.91	16.43	1.47	0.61	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	8.06	17.19	1.61	1.34	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	10.61	18.40	0.47	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.36	12.50	1.59	1.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	9.82	16.84	1.64	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.17	21.56	1.24	0.83	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.31	11.95	0.88	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.52	18.38	1.25	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.92	16.02	1.35	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.96	16.69	1.53	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	16.00	21.40	1.54	0.96	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.86	19.60	0.86	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.17	20.30	2.33	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	12.81	21.34	1.97	1.48	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.20	14.15	0.51	1.87	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	6.36	16.28	2.22	1.48	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.20	13.86	2.40	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	8.43	9.13	1.80	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.24	20.48	1.19	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	10.28	16.53	1.81	1.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.63	11.68	1.32	1.60	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	6.64	11.18	1.05	2.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	6.65	11.48	0.30	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.06	14.81	1.96	2.81	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	6.70	14.70	0.87	2.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.34	21.29	1.83	3.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	6.33	12.66	0.60	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	9.95	13.80	0.68	2.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	8.39	16.18	1.50	1.20	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.99	13.70	1.18	1.89	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	15.15	17.08	1.71	1.28	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	9.01	17.43	0.60	1.20	0.60
Schwann Cells, donor1	11498-119F4	23.32	15.23	0.75	0.19	0.19
Schwann Cells, donor2	11578-120F3	17.01	27.22	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	12.93	10.30	0.66	1.97	0.22
Sebocyte, donor1	11220-116B5	63.54	9.86	0.55	1.64	0.00
Sebocyte, donor2	11301-117B5	40.90	7.81	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	34.01	9.89	0.21	0.82	0.00
Sertoli Cells, donor1	11255-116F4	16.57	11.60	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	16.95	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	5.54	11.96	0.70	0.44	0.00
Skeletal Muscle Cells, donor2	11358-117H8	7.95	7.95	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	27.59	19.23	2.51	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	18.07	9.43	0.31	0.94	0.00
Skeletal Muscle Cells, donor5	11455-119A6	16.80	8.77	0.45	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	21.24	10.47	1.08	0.31	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	17.51	8.06	0.63	1.51	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.41	8.42	0.00	0.86	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.26	15.68	0.60	0.40	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	8.76	11.63	1.01	1.35	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.96	18.82	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	22.43	14.17	0.69	0.41	0.55
Skin - palm, donor1	10286-104F7	32.23	21.49	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.61	2.45	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	2.45	0.82	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.23	2.21	0.13	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	24.88	5.00	0.14	0.83	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	20.68	5.34	0.14	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	48.21	4.65	0.42	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	27.96	5.02	0.15	0.22	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.27	10.80	0.93	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.56	5.78	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	24.69	11.76	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.38	15.91	1.33	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.51	13.78	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	11.59	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	14.01	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.70	9.18	0.93	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.86	9.31	0.66	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	23.43	11.01	0.38	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	11.40	9.12	0.33	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	14.47	8.86	1.18	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.22	8.54	0.71	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.61	11.39	0.98	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	15.83	10.96	0.30	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.08	18.94	1.77	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	24.48	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.01	8.58	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.85	9.14	0.15	1.18	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.19	8.82	0.86	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.75	7.98	0.73	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.11	9.90	1.55	0.62	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	28.02	6.47	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.05	7.47	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	26.63	17.41	1.37	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	12.88	10.37	0.47	1.02	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.22	9.16	0.30	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.38	14.34	0.46	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	9.06	0.60	0.60	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	37.62	16.43	1.32	1.59	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.10	8.39	0.80	0.67	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.28	9.89	0.38	0.25	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.40	10.65	1.01	1.01	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.00	11.16	0.60	0.60	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	15.75	1.50	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	49.10	50.40	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	5.12	13.02	0.47	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	8.08	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.31	9.40	0.31	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	7.08	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	27.99	15.00	1.25	0.83	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.34	7.47	0.93	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.55	11.80	0.43	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.71	20.14	0.76	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.86	13.16	0.94	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.57	11.88	0.98	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	23.29	11.31	0.50	0.34	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.71	5.24	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.77	13.70	0.73	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.56	8.18	0.44	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	13.75	16.09	1.17	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.66	12.05	1.17	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.23	8.73	0.00	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.60	6.32	1.12	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.39	7.55	0.36	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.52	3.41	0.57	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	3.54	10.63	0.00	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	5.08	11.94	1.27	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	6.79	8.39	0.40	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	7.94	10.03	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	6.42	11.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	19.53	17.00	0.34	0.50	0.17
Synoviocyte, donor2	11368-117I9	27.66	16.09	0.34	0.34	0.17
Synoviocyte, donor3	11440-118H9	18.77	10.05	0.89	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	27.51	27.16	0.71	1.43	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	5.95	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.18	9.96	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	19.21	5.88	0.22	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	38.66	5.41	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	21.19	5.73	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	777.64	13.66	1.48	0.98	6.40
Urethra, donor2	10319-105A4	44.96	8.99	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	63.23	8.77	0.00	0.80	0.00
Urothelial Cells, donor2	11600-120H7	34.85	4.01	0.00	0.40	0.80
Urothelial Cells, donor3	11681-122H7	39.42	7.11	0.00	0.69	0.46
Urothelial cells, donor0	11216-116B1	45.25	11.59	0.22	1.11	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	20.47	36.48	4.45	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	31.45	32.88	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	12.32	23.27	0.68	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.74	25.14	0.69	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	8.13	24.98	3.49	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	18.74	28.11	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	29.37	35.79	0.92	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	17.35	24.65	0.91	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	25.91	16.16	1.23	0.37	0.37
Wilms' tumor cell line:HFWT	10597-108E3	25.52	14.96	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	76.81	24.02	1.12	5.31	0.00
achilles tendon, donor2	10292-104G4	31.00	16.53	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	22.18	24.22	2.04	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	25.54	20.66	1.39	2.09	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	34.07	39.29	2.97	2.37	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	49.25	22.31	1.63	2.45	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	15.46	22.77	1.69	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	15.86	19.67	1.69	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.40	13.07	1.63	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	23.79	14.98	1.32	3.08	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	9.39	16.33	1.23	2.86	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.24	22.52	1.16	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.78	14.17	0.92	0.55	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	23.40	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	24.17	14.18	0.70	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	11.91	38.06	1.81	2.33	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	7.89	21.63	0.88	2.34	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	17.20	10.69	0.93	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	14.81	27.97	0.82	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.89	12.89	0.92	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	20.48	15.36	1.71	2.56	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	23.35	20.02	2.12	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	18.05	20.22	1.44	3.37	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	8.02	14.48	0.45	1.78	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.01	15.01	2.33	2.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	11.15	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.56	10.92	0.38	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	13.08	17.45	0.44	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	7.50	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	28.97	13.19	1.18	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	27.77	16.29	0.93	0.78	0.16
adipose, donor1	10184-103D4	14.07	42.81	3.52	0.00	1.17
adipose, donor2	10185-103D5	10.54	19.87	3.65	0.00	0.00
adipose, donor3	10186-103D6	17.97	20.42	3.54	0.54	0.00
adipose, donor4	10187-103D7	13.87	31.20	6.93	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	20.04	10.57	0.47	3.16	0.32
adrenal gland, adult, pool1	10081-102A9	101.85	14.55	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	24.55	32.15	2.67	2.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	42.16	11.79	0.00	2.14	0.36
amniotic membrane cells, donor1	12235-129G3	304.88	30.84	2.55	1.39	0.23
amniotic membrane cells, donor2	12236-129G4	74.04	24.68	1.69	2.37	0.34
amniotic membrane cells, donor3	12237-129G5	291.95	33.29	2.36	3.24	1.18
amygdala - adult, donor10196	10167-103B5	24.90	22.53	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	122.47	26.77	1.62	4.46	0.61
amygdala, newborn, donor10223	10360-105E9	361.18	8.39	0.97	1.61	4.20
anaplastic carcinoma cell line:8305C	10428-106D5	17.32	15.79	0.51	1.53	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	23.17	27.14	3.53	1.54	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	12.36	24.72	6.01	2.34	0.00
aorta, adult, pool1	10052-101G7	176.72	30.20	2.16	0.59	1.37
appendix, adult	10189-103D9	46.19	22.90	0.39	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	18.57	10.66	1.38	2.06	0.00
artery, adult	10190-103E1	35.33	16.30	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	29.12	19.12	1.16	0.58	0.14
b cell line:RPMI1788	10427-106D4	58.74	10.41	0.59	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	25.25	11.93	0.55	0.28	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	34.43	10.42	0.60	0.50	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	22.60	13.89	0.67	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.10	25.17	0.56	2.24	0.56
bladder, adult, pool1	10011-101C2	41.28	25.42	1.96	0.54	0.33
blood, adult, pool1	10053-101G8	50.94	31.00	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	6.85	14.56	0.00	0.86	0.00
bone marrow, adult	10192-103E3	14.85	12.82	0.67	0.00	1.35
brain, adult, donor1	10084-102B3	29.73	10.25	2.05	1.03	2.05
brain, adult, pool1	10012-101C3	20.16	22.05	2.45	3.56	0.56
brain, fetal, pool1	10085-102B4	32.06	18.70	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	52.86	6.28	1.98	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	55.67	19.22	1.75	1.75	0.12
breast, adult, donor1	10080-102A8	202.67	11.36	0.00	0.00	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.84	2.92	0.76	1.65	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	41.74	6.49	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.91	6.22	0.46	3.22	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	28.08	9.68	0.73	2.18	0.24
carcinoid cell line:NCI-H1770	10703-109H1	13.16	15.99	1.88	7.99	0.00
carcinoid cell line:NCI-H727	10735-110B6	14.33	8.86	0.33	0.88	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	18.38	19.96	2.54	5.39	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.82	24.49	5.06	1.60	1.06
caudate nucleus - adult, donor10196	10177-103C6	37.99	13.82	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	115.46	22.59	1.67	4.52	0.67
caudate nucleus, adult, donor10258	10379-105H1	16.05	13.75	1.53	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	248.67	9.52	2.20	1.46	5.49
cerebellum - adult, donor10196	10173-103C2	11.65	32.05	2.91	14.57	2.91
cerebellum, adult, donor10252	10166-103B4	117.00	51.46	6.19	4.06	1.07
cerebellum, adult, pool1	10083-102B2	12.07	19.66	2.07	2.76	0.34
cerebellum, newborn, donor10223	10357-105E6	56.46	11.62	1.66	5.81	0.00
cerebral meninges, adult	10188-103D8	167.17	25.47	3.53	1.76	1.51
cerebrospinal fluid, donor2	10294-104G6	28.50	5.85	0.00	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	19.99	35.51	1.58	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	167.54	14.09	0.66	0.99	0.33
cervix, adult, pool1	10013-101C4	41.16	32.44	4.20	1.15	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.72	17.70	0.70	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	15.68	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	10.94	8.08	0.50	0.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	27.23	4.19	0.49	0.74	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	20.40	4.03	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	301.16	20.23	1.71	1.71	1.42
chorionic membrane cells, donor2	12239-129G7	36.69	16.01	1.29	1.09	0.30
chorionic membrane cells, donor3	12240-129G8	186.82	16.48	0.00	2.20	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	9.09	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.79	10.76	0.77	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	15.63	19.22	1.69	2.11	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.99	14.89	1.28	4.88	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	18.87	20.32	1.94	4.11	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.16	13.03	0.61	5.29	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	16.78	17.67	2.65	2.36	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	29.97	24.50	1.56	1.56	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.40	10.29	0.91	1.83	0.46
clear cell carcinoma cell line:TEN	10636-108I6	75.30	14.40	1.39	1.04	0.00
colon carcinoma cell line:CACO-2	10513-107D9	26.72	12.81	1.65	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	7.98	13.68	1.14	2.28	0.00
colon, adult, donor1	10082-102B1	34.51	13.09	0.00	0.00	2.38
colon, adult, pool1	10014-101C5	36.54	26.44	1.53	0.47	0.00
colon, fetal, donor1	10070-101I7	16.07	7.42	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	13.75	45.84	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	62.89	6.37	0.00	3.82	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	11.32	5.58	0.75	2.87	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	10.58	7.05	0.28	3.24	0.14
corpus callosum, adult, pool1	10042-101F6	93.09	24.66	2.10	2.54	0.22
cruciate ligament, donor2	10295-104G7	29.18	12.97	2.43	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	41.73	5.62	0.00	0.00	0.80
diencephalon, adult	10193-103E4	37.44	15.36	2.88	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.41	14.01	1.15	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	42.83	5.90	0.26	1.03	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	67.64	6.50	0.00	0.48	0.48
ductus deferens, adult	10196-103E7	40.37	19.93	0.50	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	15.84	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	17.66	20.60	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	10.65	13.38	0.99	0.50	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	55.07	34.20	1.11	1.33	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	32.24	28.09	2.29	0.72	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	18.50	5.55	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	14.83	3.33	0.30	1.82	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.05	8.34	0.00	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	39.40	9.19	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.15	8.38	1.01	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.61	15.77	0.36	2.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.09	6.27	0.16	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	44.02	8.00	0.33	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	80.07	12.65	0.33	0.22	0.11
epididymis, adult	10197-103E8	14.86	21.14	1.26	2.30	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	33.89	14.73	1.42	1.42	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.08	5.51	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	73.39	13.50	1.05	1.18	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	39.47	9.74	0.59	0.30	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	71.70	11.88	0.67	0.56	0.90
esophagus, adult, pool1	10015-101C6	167.87	18.58	1.81	2.12	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	11.90	13.28	1.88	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	36.22	16.90	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	31.56	10.52	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	11.91	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	34.39	5.73	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	36.43	17.49	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	35.34	22.12	2.80	1.27	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	17.18	8.59	0.13	0.64	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	22.32	18.76	1.19	2.14	0.00
frontal lobe, adult, pool1	10040-101F4	18.58	21.39	4.13	3.66	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	82.87	11.41	0.30	0.90	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	27.07	14.26	0.46	2.38	0.18
gall bladder, adult	10198-103E9	26.56	22.69	1.93	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	24.16	52.61	1.61	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	32.12	53.41	0.75	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	64.84	12.67	1.48	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	41.00	15.28	0.97	1.35	0.39
gastric cancer cell line:AZ521	10549-107H9	20.33	17.54	0.98	0.66	0.00
gastric cancer cell line:GSS	10560-108A2	40.27	11.90	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.71	12.79	0.91	2.74	0.69
giant cell carcinoma cell line:LU65	10487-107B1	8.38	16.52	1.49	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	92.23	10.22	0.28	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.68	4.99	0.75	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.85	16.78	1.16	1.79	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.71	18.68	2.11	2.11	0.42
glioblastoma cell line:T98G	10485-107A8	20.97	21.30	0.99	1.88	0.44
glioma cell line:GI-1	10413-106B8	26.94	18.45	2.34	1.76	0.00
globus pallidus - adult, donor10196	10175-103C4	34.99	22.60	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	180.14	16.84	1.22	1.22	0.73
globus pallidus, adult, donor10258	10367-105F7	36.97	17.80	2.74	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	75.14	7.46	0.00	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	48.94	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	54.64	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	41.81	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	9.28	12.48	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	7.35	26.63	1.84	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	5.94	23.78	0.91	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	8.37	23.83	1.29	0.64	0.00
hIPS, biol_rep1	14380-156B6	2.87	23.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.86	17.15	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	20.97	23.17	0.00	4.41	0.00
hairy cell leukemia cell line:Mo	10712-109I1	22.70	12.64	0.29	0.86	0.29
heart - mitral valve, adult	10205-103F7	219.74	18.24	0.60	0.30	2.09
heart - pulmonic valve, adult	10206-103F8	16.47	14.90	1.57	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	360.53	22.48	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	44.69	12.45	1.02	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	9.79	11.07	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	29.90	12.19	1.15	0.00	0.23
heart, fetal, pool1	10046-101G1	46.41	21.46	2.36	0.41	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.26	8.64	0.93	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	71.35	13.08	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	73.92	12.71	0.77	0.44	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	86.05	12.38	0.49	0.24	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	67.91	13.95	0.71	0.81	0.30
hepatoma cell line:Li-7	10484-107A7	16.13	15.13	0.67	0.56	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.55	14.07	0.80	1.41	0.00
hippocampus - adult, donor10196	10169-103B7	19.87	23.66	0.00	2.84	1.89
hippocampus, adult, donor10252	10153-102I9	146.34	24.29	1.22	2.86	1.22
hippocampus, adult, donor10258	10374-105G5	15.44	19.92	1.00	2.99	0.00
hippocampus, newborn, donor10223	10363-105F3	93.41	12.69	2.11	1.06	3.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.10	29.91	2.44	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.27	20.03	2.36	0.39	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	3.30	22.60	3.30	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.07	30.45	3.38	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	9.55	38.47	3.61	0.52	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.77	45.93	4.93	1.14	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	17.81	30.95	3.21	2.04	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	23.05	23.91	3.23	0.86	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	14.18	30.86	2.09	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.13	21.55	4.03	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	9.32	24.11	3.54	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	5.39	18.18	4.04	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	6.10	17.53	2.03	0.16	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.37	19.16	1.47	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	4.36	13.96	1.75	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	11.65	31.12	2.10	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.47	34.01	3.05	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	4.00	25.49	2.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.25	22.98	2.45	0.57	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	21.83	1.82	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.70	29.76	2.82	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	10.12	19.11	1.80	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	7.55	18.58	0.58	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.18	23.02	1.79	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	10.53	19.58	0.74	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	9.13	15.41	1.43	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	7.76	18.37	0.82	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.15	29.57	1.76	0.35	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	11.72	21.54	4.12	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	5.75	26.03	3.03	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.07	19.13	4.14	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	6.64	20.59	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.95	21.29	2.82	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.59	21.73	2.81	1.02	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	20.45	6.06	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.40	18.15	2.02	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	10.14	22.46	4.59	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	5.35	19.16	1.78	0.45	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.29	25.37	1.95	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	8.56	32.70	2.14	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	84.58	16.27	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	8.60	42.03	4.63	0.99	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.87	26.27	2.74	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.11	26.78	1.09	1.09	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.83	25.98	1.78	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	16.71	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	18.15	31.28	4.06	0.27	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.54	22.09	2.96	1.08	0.54
immature langerhans cells, donor1	11904-125F5	56.90	25.18	1.70	0.00	0.24
immature langerhans cells, donor2	11905-125F6	121.20	21.39	1.58	0.00	2.38
insula, adult, pool1	10039-101F3	25.55	27.92	3.22	4.35	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	30.56	7.80	0.00	0.65	0.33
kidney, adult, pool1	10017-101C8	28.14	14.92	1.90	1.00	0.20
kidney, fetal, pool1	10045-101F9	137.23	25.39	2.90	0.57	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	57.23	16.47	1.14	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.48	6.36	0.28	0.14	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	37.07	7.52	0.37	0.55	0.37
left atrium, adult, donor1	10079-102A7	4.36	7.63	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	14.16	8.60	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	30.92	15.60	0.55	1.09	0.27
leiomyoma cell line:10964C	10569-108B2	17.96	4.67	0.00	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	15.22	4.35	0.00	0.00	1.63
leiomyoma cell line:15425	10571-108B4	16.27	8.98	0.73	1.70	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	28.23	27.18	3.14	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	67.18	43.56	2.48	1.30	0.24
liposarcoma cell line:KMLS-1	10782-110G8	17.18	12.34	0.62	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	20.83	10.36	0.37	2.19	0.00
liver, adult, pool1	10018-101C9	27.23	8.91	0.81	0.32	0.32
liver, fetal, pool1	10086-102B5	164.62	11.29	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	51.04	12.40	1.31	1.90	1.02
locus coeruleus, adult, donor10252	10165-103B3	213.16	14.39	1.29	4.24	1.48
locus coeruleus, adult, donor10258	10375-105G6	32.16	13.82	1.13	1.41	0.56
locus coeruleus, newborn, donor10223	10362-105F2	59.73	10.09	0.84	2.52	2.94
lung adenocarcinoma cell line:A549	10499-107C4	16.19	4.84	0.28	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	6.89	1.38	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	66.04	9.89	0.66	0.66	0.26
lung, adult, pool1	10019-101D1	111.39	21.38	0.71	0.35	0.24
lung, fetal, donor1	10068-101I5	82.77	33.96	0.00	1.71	0.29
lung, right lower lobe, adult, donor1	10075-102A3	50.86	13.75	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	14.20	9.94	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	17.10	8.77	0.44	0.44	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.73	22.94	1.96	0.60	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	79.85	14.44	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	467.52	21.76	1.78	0.00	1.78
mature adipocyte, donor2	12232-129F9	243.64	19.92	1.04	0.21	0.21
mature adipocyte, donor3	12233-129G1	259.11	19.44	0.95	0.00	1.19
mature adipocyte, donor4	12234-129G2	461.68	23.43	1.32	0.79	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	23.59	12.39	1.67	2.38	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	38.35	1.13	6.77	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	88.09	25.75	2.76	6.80	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	7.94	19.70	1.59	1.91	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	190.64	17.91	2.56	1.28	11.52
medial temporal gyrus - adult, donor10196	10183-103D3	21.09	26.33	2.19	5.74	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	97.20	24.83	1.49	3.18	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	228.28	11.84	2.51	0.72	2.51
medulla oblongata - adult, donor10196	10174-103C3	53.22	16.22	0.65	1.95	1.30
medulla oblongata, adult, donor10252	10155-103A2	265.02	18.73	1.70	3.25	1.70
medulla oblongata, adult, pool1	10038-101F2	66.28	14.20	1.31	2.29	0.00
medulla oblongata, newborn, donor10223	10361-105F1	72.21	12.15	1.04	4.17	1.74
medulloblastoma cell line:D283 Med	10838-111E1	32.10	28.12	2.66	2.21	0.44
medulloblastoma cell line:ONS-76	10759-110E3	55.88	20.05	1.35	0.98	0.12
melanoma cell line:COLO 679	10514-107E1	27.60	7.04	1.01	0.72	0.00
melanoma cell line:G-361	10465-106H6	37.19	16.83	1.09	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	39.26	7.24	0.36	0.54	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.98	31.72	5.29	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	13.74	23.07	2.07	2.85	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	15.19	13.35	1.23	0.77	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.36	9.82	0.36	1.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.42	5.38	0.41	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.45	8.99	0.42	1.26	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.79	10.59	0.77	0.96	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	15.96	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	38.27	9.44	0.17	1.03	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	22.66	9.43	0.81	0.46	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.00	9.55	0.27	1.19	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.95	13.10	0.68	1.08	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.05	9.39	0.57	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.19	8.89	0.99	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.04	10.79	0.83	0.83	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	7.33	8.73	0.70	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.58	11.23	0.41	0.82	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.63	7.19	0.72	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.00	8.59	0.41	0.52	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.26	4.56	0.91	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	30.63	12.59	1.26	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.36	9.41	0.45	1.05	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	23.28	9.80	0.44	0.88	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.62	11.78	0.74	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.30	6.01	0.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	22.73	21.89	1.68	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.50	8.22	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.91	11.25	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.85	10.21	0.79	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.93	9.86	0.92	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.71	8.24	0.71	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.15	11.17	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.47	8.25	1.18	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.56	8.34	0.46	1.39	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.23	8.94	0.29	1.15	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.37	10.71	0.45	0.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.93	6.01	0.48	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.07	12.47	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.06	8.06	0.67	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.60	9.01	0.82	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.44	6.87	0.43	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	10.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.85	11.37	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	7.27	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.73	12.26	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	8.18	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.05	10.88	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	6.30	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	8.94	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.74	10.08	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	10.97	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	4.43	5.70	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.86	6.21	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	8.60	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	17.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.19	5.30	0.81	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	4.77	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	8.25	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.91	10.91	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	9.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	5.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	5.14	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	5.51	9.64	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.24	6.43	1.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	20.19	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.99	7.63	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	26.60	5.64	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	8.72	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	32.94	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.99	6.07	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	3.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	10.91	6.75	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.68	5.52	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	12.22	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	28.63	8.51	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	36.62	12.99	1.42	0.71	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.61	12.05	0.93	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.42	9.45	0.21	0.82	0.10
mesothelioma cell line:Mero-25	10850-111F4	6.13	7.72	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	21.02	21.27	1.71	0.98	0.00
mesothelioma cell line:Mero-48a	10852-111F6	15.72	14.39	0.44	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	21.55	12.09	0.26	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	27.75	7.66	0.68	0.68	0.17
mesothelioma cell line:Mero-84	10855-111F9	24.52	9.61	0.51	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	16.15	9.52	0.00	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	25.34	8.61	0.33	0.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	24.07	7.96	0.54	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	12.47	12.64	0.68	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	9.67	23.67	1.78	0.00	0.51
mesothelioma cell line:No36	10857-111G2	27.40	24.47	2.28	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	17.34	7.32	0.00	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	9.02	17.85	1.92	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	8.55	19.05	1.59	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	4.85	14.72	2.33	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	21.55	12.73	0.00	0.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.90	13.78	1.91	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	31.79	14.28	0.46	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.75	8.18	0.38	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.03	26.79	1.85	6.10	0.18
myeloma cell line:PCM6	10474-106I6	9.88	19.96	1.19	1.98	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.83	10.65	0.00	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	43.74	32.36	2.55	0.98	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	36.10	7.58	0.67	0.56	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	28.17	7.57	0.22	0.51	0.44
nasal epithelial cells, donor2	12227-129F4	38.64	15.46	2.21	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	11.04	23.70	3.91	1.15	0.00
neuroblastoma cell line:NB-1	10539-107G8	6.74	29.56	3.37	1.50	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	10.33	17.08	1.05	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	92.99	31.12	3.35	1.68	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7.83	9.73	0.47	1.42	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	41.97	11.40	1.58	0.63	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	6.84	15.50	0.60	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.80	13.99	4.45	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	15.97	11.18	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	74.37	74.37	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	47.35	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	262.98	47.18	3.04	5.24	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.81	22.41	2.40	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	19.24	11.86	0.96	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.40	11.04	0.79	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	36.93	23.72	2.81	3.00	0.19
occipital cortex - adult, donor10196	10172-103C1	14.42	28.85	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	155.38	26.84	2.42	4.56	0.81
occipital cortex, newborn, donor10223	10355-105E4	179.06	14.56	2.18	2.18	1.82
occipital lobe, adult, donor1	10076-102A4	20.99	28.34	3.41	0.79	1.05
occipital lobe, fetal, donor1	10073-102A1	6.87	23.60	5.58	1.72	0.43
occipital pole, adult, pool1	10036-101E9	17.42	25.39	3.39	3.23	0.08
olfactory region, adult	10195-103E6	22.93	19.87	2.10	3.25	0.19
optic nerve, donor1	10277-104E7	24.01	8.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	72.33	15.15	0.91	2.73	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	73.50	15.80	1.51	1.79	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.77	5.93	0.17	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	58.79	11.09	0.92	0.46	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	17.05	14.11	1.76	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.95	4.67	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	29.90	18.66	1.06	1.70	0.21
ovary, adult, pool1	10020-101D2	23.93	27.34	3.41	0.96	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	22.37	8.98	0.73	1.65	0.00
pancreas, adult, donor1	10049-101G4	69.61	13.17	1.88	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	15.09	4.47	0.56	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	29.81	10.90	0.34	0.68	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	64.41	8.44	0.66	1.66	0.33
paracentral gyrus, adult, pool1	10035-101E8	27.27	24.16	4.03	2.75	0.27
parietal cortex, adult, donor10258	10373-105G4	8.81	16.15	0.73	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	25.39	26.33	3.76	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	127.70	27.93	2.28	5.13	0.57
parietal lobe, adult, pool1	10034-101E7	33.84	26.61	4.05	2.56	0.00
parietal lobe, fetal, donor1	10072-101I9	1.94	18.43	1.94	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	252.36	13.09	2.99	1.50	4.11
parotid gland, adult	10199-103F1	16.03	18.50	2.47	0.62	0.62
penis, adult	10200-103F2	30.08	16.11	1.07	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	169.76	17.11	0.74	1.86	2.97
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	50.70	12.97	0.58	0.87	0.15
pineal gland - adult, donor10196	10179-103C8	27.09	22.58	0.65	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	135.02	54.48	2.96	6.51	0.00
pineal gland, adult, donor10258	10377-105G8	35.74	32.61	0.63	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	15.18	13.15	4.05	5.06	0.00
pituitary gland, adult, donor10252	10162-103A9	67.75	51.08	6.78	3.13	0.00
pituitary gland, adult, donor10258	10378-105G9	8.51	23.83	3.40	6.81	0.00
placenta, adult, pool1	10021-101D3	53.75	20.32	2.47	1.40	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	15.76	13.51	0.40	0.93	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	21.48	11.67	0.47	0.47	0.62
pons, adult, pool1	10033-101E6	39.50	16.09	1.46	2.75	0.26
postcentral gyrus, adult, pool1	10032-101E5	18.13	26.68	4.36	3.23	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	25.10	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	22.03	5.51	5.51	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	46.94	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	39.91	8.89	0.44	5.24	0.00
prostate cancer cell line:PC-3	10439-106E7	45.01	15.61	1.27	3.45	0.18
prostate, adult, pool1	10022-101D4	94.68	27.75	2.45	0.09	0.18
putamen, adult, donor10196	10176-103C5	45.56	25.49	4.49	5.67	0.00
putamen, adult, donor10252	10152-102I8	47.06	21.57	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	3.28	9.84	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	11.60	18.36	3.62	1.45	0.00
putamen, newborn, donor10223	10365-105F5	75.72	6.00	0.00	3.00	3.75
rectal cancer cell line:TT1TKB	10469-106I1	66.62	5.53	1.16	0.29	0.58
rectum, fetal, donor1	10067-101I4	26.43	16.69	2.78	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	27.77	15.90	1.06	1.91	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	5.80	20.30	1.24	1.66	0.00
retina, adult, pool1	10030-101E3	32.40	27.43	2.78	1.29	0.10
retinoblastoma cell line:Y79	10475-106I7	13.77	28.58	3.90	4.94	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	13.89	13.89	0.74	0.98	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.87	22.78	3.37	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	11.37	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	17.97	6.96	0.49	1.13	0.00
salivary acinar cells, donor2	11772-123I8	32.08	11.43	1.24	0.55	0.28
salivary acinar cells, donor3	11773-123I9	64.22	10.59	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	35.46	19.45	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	20.07	16.95	1.52	3.63	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.04	18.10	1.41	3.53	0.24
seminal vesicle, adult	10201-103F3	120.63	28.57	3.17	1.59	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	116.85	18.46	1.46	0.97	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.85	13.59	1.01	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	16.06	5.02	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.83	3.49	0.00	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	18.46	4.75	0.00	0.33	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	34.19	9.55	1.03	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	8.51	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	7.32	10.19	1.32	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	24.12	26.13	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	41.03	32.19	1.89	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.68	10.67	3.34	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	83.21	47.28	0.95	5.67	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.54	15.42	2.31	1.73	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	9.40	11.70	1.15	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.31	50.19	3.70	4.83	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.09	8.72	1.09	0.87	0.00
small intestine, adult, pool1	10024-101D6	17.80	24.72	2.51	0.24	0.24
small intestine, fetal, donor1	10064-101I1	17.44	21.38	1.97	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.62	31.80	3.59	5.64	1.03
smooth muscle, adult, pool1	10048-101G3	57.12	26.88	2.33	0.52	0.52
somatostatinoma cell line:QGP-1	10781-110G7	13.94	22.78	2.41	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	48.63	8.72	0.92	1.15	0.92
spinal cord, adult, donor10252	10159-103A6	224.73	14.59	0.79	1.97	1.58
spinal cord, adult, donor10258	10369-105F9	34.59	14.53	1.38	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	35.37	26.83	5.49	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	44.54	11.02	0.92	2.30	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	15.08	11.05	0.30	0.30	0.15
spleen, adult, pool1	10025-101D7	9.25	13.99	0.44	0.00	0.11
spleen, fetal, pool1	10044-101F8	249.81	19.63	0.79	0.56	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	10.87	11.90	0.93	0.21	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	65.51	3.99	0.19	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	59.76	16.77	1.40	1.05	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	68.02	13.29	0.78	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	19.70	26.11	1.91	0.45	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	32.19	10.17	1.27	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.00	8.88	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	25.63	24.56	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	30.19	25.64	1.71	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	265.66	12.88	0.21	0.83	2.28
substantia nigra, adult, donor10258	10371-105G2	16.55	18.62	0.52	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	50.17	6.36	0.00	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.76	31.64	4.81	2.29	0.00
temporal lobe, adult, pool1	10031-101E4	26.87	24.16	3.90	2.54	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.97	34.90	9.26	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	5.27	27.69	7.91	2.20	1.32
tenocyte, donor1	11763-123H8	14.66	11.87	1.40	0.70	0.35
tenocyte, donor2	11765-123I1	15.64	11.06	0.38	0.00	0.76
tenocyte, donor3	11768-123I4	15.57	9.64	1.48	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	13.26	22.09	2.21	0.68	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	14.64	17.73	1.54	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	12.71	16.27	0.46	0.77	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	16.50	15.87	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	284.76	15.88	1.51	0.38	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	689.60	13.41	0.22	0.33	4.25
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	23.78	12.38	2.93	0.33	1.30
testis, adult, pool1	10026-101D8	59.70	119.61	19.43	34.68	1.50
testis, adult, pool2	10096-102C6	57.74	138.93	14.89	45.56	3.61
thalamus - adult, donor10196	10168-103B6	45.26	19.87	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	192.07	14.22	0.78	2.50	1.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	23.09	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	22.07	11.03	1.32	0.99	0.16
thalamus, newborn, donor10223	10366-105F6	100.68	10.93	1.15	3.45	1.73
throat, adult	10209-103G2	68.41	17.73	1.25	0.50	1.00
throat, fetal, donor1	10061-101H7	22.24	19.20	2.44	2.13	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	7.35	18.08	1.79	0.99	0.20
thymus, adult, pool1	10027-101D9	26.64	35.79	3.18	1.19	0.00
thymus, fetal, pool1	10043-101F7	601.40	35.02	1.97	3.01	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.67	8.11	0.40	1.06	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	30.59	14.11	1.40	0.56	0.14
thyroid, adult, pool1	10028-101E1	105.44	26.78	2.99	1.40	0.93
thyroid, fetal, donor1	10060-101H6	51.41	14.50	2.37	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	24.64	0.00	0.00	0.00
tongue, adult	10203-103F5	49.07	13.95	1.40	1.16	0.93
tongue, fetal, donor1	10059-101H5	55.17	20.89	1.97	0.39	0.00
tonsil, adult, pool1	10047-101G2	135.24	22.84	1.10	0.90	0.40
trachea, adult, pool1	10029-101E2	92.35	17.50	1.15	1.55	0.16
trachea, fetal, donor1	10058-101H4	61.94	20.77	1.54	1.92	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.40	16.65	0.35	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	27.36	9.93	0.41	0.61	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.49	18.65	2.35	2.66	0.16
tridermal teratoma cell line:HGRT	10694-109G1	24.73	11.42	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	23.96	8.47	1.02	0.17	0.08
umbilical cord, fetal, donor1	10057-101H3	27.12	12.52	4.17	2.09	0.00
uterus, adult, pool1	10100-102D1	66.89	29.18	4.10	1.02	0.17
uterus, fetal, donor1	10055-101H1	49.15	23.04	2.05	1.54	0.51
vagina, adult	10204-103F6	1065.58	14.22	0.00	0.65	11.63
vein, adult	10191-103E2	29.37	19.51	2.19	0.22	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	10.41	9.35	0.53	0.27	0.00